Automate Your Wheel Strategy on HSIC
With Tiblio's Option Bot, you can configure your own wheel strategy including HSIC - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol HSIC
- Rev/Share 104.7585
- Book/Share 40.1795
- PB 2.5837
- Debt/Equity 0.9747
- CurrentRatio 1.411
- ROIC 0.0562
- MktCap 8949900229.0
- FreeCF/Share 2.9362
- PFCF 24.9997
- PE 22.8811
- Debt/Assets 0.3079
- DivYield 0
- ROE 0.114
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 4
- P/B Score 3
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | HSIC | Evercore ISI | In-line | Outperform | -- | $83 | Aug. 26, 2025 |
| Downgrade | HSIC | Stifel | Buy | Hold | -- | $75 | July 25, 2025 |
| Downgrade | HSIC | Robert W. Baird | Outperform | Neutral | -- | $72 | July 14, 2025 |
| Initiation | HSIC | Wells Fargo | -- | Equal Weight | -- | $80 | Feb. 14, 2025 |
| Upgrade | HSIC | BofA Securities | Underperform | Buy | $69 | $84 | Jan. 6, 2025 |
| Initiation | HSIC | Mizuho | -- | Neutral | -- | $75 | Dec. 4, 2024 |
News
Henry Schein: An Industry Leader That Offers Some Upside From Here
Published: March 04, 2025 by: Seeking Alpha
Sentiment: Positive
Henry Schein is the world's largest provider of healthcare products and services for office-based dental and medical practitioners, showing consistent growth through acquisitions. Despite a 3% dip in shares, management's 2025 guidance indicates continued growth, justifying a bullish stance on the stock. The firm reported a 5.8% revenue increase in Q4 2024, driven by organic growth and acquisitions, with significant improvements in net income and operating cash flow.
Read More
HSIC Q4 Earnings Match Estimates, Margins Up, Stock Falls in Premarket
Published: February 25, 2025 by: Zacks Investment Research
Sentiment: Positive
Henry Schein's fourth-quarter results reflect stable dental and medical end-markets.
Read More
Henry Schein Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Detailed 2025 Financial Guidance
Published: February 25, 2025 by: Business Wire
Sentiment: Neutral
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today reported financial results for the fourth quarter and full year ended December 28, 2024. The financial results and guidance being provided today are consistent with the preliminary financial results and guidance provided on January 29th. “Our fourth quarter financial results reflect relatively stable dental and medical.
Read More
HSIC Gears Up for Q4 Earnings: Here's What You Need to Know
Published: February 17, 2025 by: Zacks Investment Research
Sentiment: Positive
Henry Schein is expected to report impressive sales in both its businesses in the fourth quarter of 2024, along with a positive pace of recovery from the cyber incident.
Read More
About Henry Schein, Inc. (HSIC)
- IPO Date 1995-11-03
- Website https://www.henryschein.com
- Industry Medical - Distribution
- CEO Stanley M. Bergman CPA
- Employees 25000